Literature DB >> 10672753

Smokeless tobacco use among urban white and black South Africans.

K Peltzer1.   

Abstract

A telephone survey was conducted to compare the extent of smokeless tobacco use and perception of related health risks by white and black urban South Africans. Using systematic random sampling, one out of every 20 phone numbers was selected from the Seshego (blacks) and Pietersburg (whites) telephone directory until 300 tobacco users in each site were identified. Among the white group, cigarette smoking was clearly predominant (290) and only 10 used snuff, whereas among the black sample almost half (46.7%) of the tobacco users used snuff, especially women (40%). Although a majority acknowledged negative effects of snuff use on their health and its addictive character, 42% either do not believe or do not know that snuff contains nicotine and causes cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10672753     DOI: 10.2466/pr0.1999.85.3.933

Source DB:  PubMed          Journal:  Psychol Rep        ISSN: 0033-2941


  4 in total

1.  Pitfalls in the assessment of smoking status detected in a cohort of South African RA patients.

Authors:  Nimmisha Govind; Mahmood M T M Ally; Mohammed Tikly; Ronald Anderson; Bridget Hodkinson; Pieter W A Meyer
Journal:  Rheumatol Int       Date:  2016-07-08       Impact factor: 2.631

2.  Smokeless tobacco use, tooth loss and oral health issues among adults in Cameroon.

Authors:  M A Agbor; C C Azodo; T S M Tefouet
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

3.  Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South Africa.

Authors:  O A Ayo-Yusuf; T J P Swart; W B Pickworth
Journal:  Tob Control       Date:  2004-06       Impact factor: 7.552

4.  Intention to switch to smokeless tobacco use among South African smokers: results from the 2007 South African Social Attitudes Survey.

Authors:  Olalekan A Ayo-Yusuf; Israel T Agaku
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.